← FDA Drug Approvals (Drugs@FDA)
AYVAKIT
NDA · New Drug Application · Sponsor: BLUEPRINT MEDICINES · Approved 2020-01-09
Drug application
- FDA Application #
NDA212608- Application type
- New Drug Application
- Brand name
- AYVAKIT
- Generic name
- AVAPRITINIB
- Active ingredients
- AVAPRITINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- BLUEPRINT MEDICINES
- Manufacturer
- Blueprint Medicines Corporation
- First approval
- 2020-01-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown